{"ModuleTitle": "Company Description", "CompanyName": "MacroGenics, Inc.", "Symbol": "MGNX", "Address": "9704 MEDICAL CENTER DRIVE, Rockville, Maryland, 20850, United States of America", "Phone": "301-251-5172", "Industry": "Major Pharmaceuticals", "Sector": "Health Care", "Region": "North America", "CompanyDescription": "Except as otherwise indicated herein or as the context otherwise requires,\r\nreferences in this annual report on Form 10-K to \"MacroGenics,\" the \"company,\"\r\n\"we,\" \"us\" and \"our\" refer to MacroGenics, Inc. and its consolidated\r\nsubsidiaries. MacroGenics\u00ae, the MacroGenics logo\u00ae, DART\u00ae, TRIDENTTM and the\r\nphrases \"Breakthrough Biologics, Life-Changing Medicines\" and \"Developing\r\nBreakthrough Biologics, Life-Changing Medicines\" are our trademarks. The other\r\ntrademarks, trade names and service marks appearing in this report are the\r\nproperty of their respective owners.\r\nOverview\r\nWe are a clinical-stage biopharmaceutical company focused on discovering and\r\ndeveloping innovative antibody-based therapeutics designed to modulate the human\r\nimmune response for the treatment of cancer.&nbsp;&nbsp;... <a href=\"http://secfilings.nasdaq.com/edgar_conv_html%2f2020%2f02%2f25%2f0001125345-20-000031.html#FIS_BUSINESS\" target=\"_blank\">More</a> ...&nbsp;&nbsp;\r\n", "KeyExecutives": [{"name": "Eric Risser", "title": "Chief Business Officer & SVP-Business Development"}, {"name": "Ezio Bonvini", "title": "Chief Scientific Officer & Senior VP-Research"}, {"name": "James Karrels", "title": "Chief Financial Officer, Secretary & Senior VP"}, {"name": "Scott E. Koenig", "title": "President, Chief Executive Officer & Director"}], "Number_of_employees": ["NO INFO"], "Subsidiaries": ["NO INFO"]}